These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 20705090)

  • 21. A new avenue for lithium: intervention in traumatic brain injury.
    Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
    ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
    Chuang DM
    Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium and autophagy.
    Motoi Y; Shimada K; Ishiguro K; Hattori N
    ACS Chem Neurosci; 2014 Jun; 5(6):434-42. PubMed ID: 24738557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of lithium effects on brain and blood.
    Young W
    Cell Transplant; 2009; 18(9):951-75. PubMed ID: 19523343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness.
    Moore GJ; Bebchuk JM; Parrish JK; Faulk MW; Arfken CL; Strahl-Bevacqua J; Manji HK
    Am J Psychiatry; 1999 Dec; 156(12):1902-8. PubMed ID: 10588403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage].
    Pronin AV; Gogoleva IV; Torshin IY; Gromovа OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2):99-108. PubMed ID: 27166488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A literature review.
    Wang W; Lu D; Shi Y; Wang Y
    Int J Med Sci; 2024; 21(2):284-298. PubMed ID: 38169754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free and Bound Therapeutic Lithium in Brain Signaling.
    Dudev T; Mazmanian K; Weng WH; Grauffel C; Lim C
    Acc Chem Res; 2019 Oct; 52(10):2960-2970. PubMed ID: 31556294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
    Guttuso T
    Med Hypotheses; 2019 Oct; 131():109302. PubMed ID: 31443765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
    Gould TD; Manji HK
    Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
    Malhi GS; Outhred T
    CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
    Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
    Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium and Therapeutic Targeting of GSK-3.
    Snitow ME; Bhansali RS; Klein PS
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.
    Bortolozzi A; Fico G; Berk M; Solmi M; Fornaro M; Quevedo J; Zarate CA; Kessing LV; Vieta E; Carvalho AF
    Pharmacol Rev; 2024 May; 76(3):323-357. PubMed ID: 38697859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases.
    Wada A; Yokoo H; Yanagita T; Kobayashi H
    J Pharmacol Sci; 2005 Dec; 99(4):307-21. PubMed ID: 16340157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease.
    Singulani MP; Ferreira AFF; Figueroa PS; Cuyul-Vásquez I; Talib LL; Britto LR; Forlenza OV
    Ageing Res Rev; 2024 Mar; 95():102231. PubMed ID: 38364914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential mechanisms of action of lithium in bipolar disorder. Current understanding.
    Malhi GS; Tanious M; Das P; Coulston CM; Berk M
    CNS Drugs; 2013 Feb; 27(2):135-53. PubMed ID: 23371914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
    Bauer M; Alda M; Priller J; Young LT;
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurobiology of lithium: an update.
    Lenox RH; McNamara RK; Papke RL; Manji HK
    J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.